Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
<p>Abstract</p> <p>Background</p> <p>There are no standard criteria for when to discontinue intravenous antimicrobial therapy (IVAMT) in children with febrile neutropenia (FN), but it is now common to discontinue IVAMT and discharge patients with an absolute neutrophil...
Saved in:
Main Authors: | Grundy Paul E (Author), Hodgson-Viden Heather (Author), Robinson Joan L (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2005-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of mortality in pediatric oncology patients with febrile neutropenia
by: Aditya Dabas, et al.
Published: (2022) -
Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
by: Federica Cennamo, et al.
Published: (2021) -
Time to antibiotic administration and outcome of febrile neutropenia in pediatric oncology patients
by: Mitali Sharma, et al.
Published: (2022) -
Low albumin at the onset of febrile neutropenia predicts adverse outcome in pediatric febrile neutropenia
by: Manideepa Maji, et al.
Published: (2022) -
Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
by: Karen A. Monuszko, et al.
Published: (2021)